4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

650.00p
   
  • Change Today:
    -35.00p
  • 52 Week High: 720.00
  • 52 Week Low: 310.00
  • Currency: UK Pounds
  • Shares Issued: 12.32m
  • Volume: 1,580
  • Market Cap: 80.06m

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

4basebio Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.20 (0.53) (5.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.46 (0.72) (8.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

4basebio Company Announcements

Second Price Monitoring Extn 04-Aug-2021 16:40 RNS
Price Monitoring Extension 04-Aug-2021 16:35 RNS
4basebio UK Societas - Further re Conversion to ... 23-Jul-2021 15:39 PR Newswire

Latest 4basebio Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

4basebio Market Data

Currency UK Pounds
Share Price 650.00p
Change Today -35.00p
% Change -5.11 %
52 Week High 720.00
52 Week Low 310.00
Volume 1,580
Shares Issued 12.32m
Market Cap 80.06m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
22.33% above the market average22.33% above the market average22.33% above the market average22.33% above the market average22.33% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
Income Not Available
Growth Not Available

4basebio Dividends

No dividends found

Trades for 17-Sep-2021

Time Volume / Share Price
16:35 1,395 @ 650.00p
11:05 57 @ 704.00p
09:16 128 @ 650.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page